GPR37 is processed in the N‐terminal ectodomain by ADAM10 and furin

dc.contributor.authorMattila, S. Orvokki
dc.contributor.authorTuhkanen, Hanna E.
dc.contributor.authorLackman, Jarkko J.
dc.contributor.authorKonzack, Anja
dc.contributor.authorMorató Arús, Xavier
dc.contributor.authorArgerich, Josep
dc.contributor.authorSaftig, Paul
dc.contributor.authorCiruela Alférez, Francisco
dc.contributor.authorPetäjä-Repo, Ulla E.
dc.date.accessioned2021-06-10T16:09:24Z
dc.date.available2021-06-10T16:09:24Z
dc.date.issued2021-05-27
dc.date.updated2021-06-10T15:14:52Z
dc.description.abstractGPR37 is an orphan G protein-coupled receptor (GPCR) implicated in several neurological diseases and important physiological pathways in the brain. We previously reported that its long N-terminal ectodomain undergoes constitutive metalloprotease-mediated cleavage and shedding, which have been rarely described for class A GPCRs. Here, we demonstrate that the protease that cleaves GPR37 at Glu167↓Gln168 is a disintegrin and metalloprotease 10 (ADAM10). This was achieved by employing selective inhibition, RNAi-mediated downregulation, and genetic depletion of ADAM10 in cultured cells as well as in vitro cleavage of the purified receptor with recombinant ADAM10. In addition, the cleavage was restored in ADAM10 knockout cells by overexpression of the wild type but not the inactive mutant ADAM10. Finally, postnatal conditional depletion of ADAM10 in mouse neuronal cells was found to reduce cleavage of the endogenous receptor in the brain cortex and hippocampus, confirming the physiological relevance of ADAM10 as a GPR37 sheddase. Additionally, we discovered that the receptor is subject to another cleavage step in cultured cells. Using site-directed mutagenesis, the site (Arg54↓Asp55) was localized to a highly conserved region at the distal end of the ectodomain that contains a recognition site for the proprotein convertase furin. The cleavage by furin was confirmed by using furin-deficient human colon carcinoma LoVo cells and proprotein convertase inhibitors. GPR37 is thus the first multispanning membrane protein that has been validated as an ADAM10 substrate and the first GPCR that is processed by both furin and ADAM10. The unconventional N-terminal processing may represent an important regulatory element for GPR37.
dc.format.extent18 p.
dc.format.mimetypeapplication/pdf
dc.identifier.pmid34042202
dc.identifier.urihttps://hdl.handle.net/2445/178252
dc.language.isoeng
dc.publisherWiley
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1096/fj.202002385RR
dc.relation.ispartofThe FASEB Journal, 2021, vol. 35, num. 6
dc.relation.urihttps://doi.org/10.1096/fj.202002385RR
dc.rightscc by-nc (c) Mattila et al., 2021
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by-nc/3.0/es/*
dc.sourceArticles publicats en revistes (Patologia i Terapèutica Experimental)
dc.subject.classificationMalalties del sistema nerviós
dc.subject.classificationFisiologia
dc.subject.otherNervous system Diseases
dc.subject.otherPhysiology
dc.titleGPR37 is processed in the N‐terminal ectodomain by ADAM10 and furin
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
fj.202002385RR.pdf
Mida:
1.58 MB
Format:
Adobe Portable Document Format